학술논문

P683: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES (TRIAL IN PROGRESS)
Document Type
article
Source
HemaSphere, Vol 6, Pp 579-580 (2022)
Subject
Diseases of the blood and blood-forming organs
RC633-647.5
Language
English
ISSN
2572-9241